Buckeye BioLaunch
About the program
Buckeye BioLaunch
New 2026 initiative for AI-driven therapeutic discovery and commercialization. Collaboration between Wexner Medical Center, OSUCCC-James, Colleges of Medicine and Pharmacy. Directors: Deanna Kroetz and Xiaolin Cheng. Aims to support 10-20 AI-driven screening projects annually. Anchored in the Innovation District. Complements the AI Faculty Hiring Initiative (100 new faculty) and AI(X) Hub.
Also known as: Buckeye BioLaunch Initiative
Key numbers
Funding range
Not listed
Funding available
Equity
Unknown
Application
Annual
Faculty, Staff, Graduate Students · Institution Wide
Last activity
Not recorded
Active
Keep this on your radar Deadline reminders ↓
Reminders
Buckeye BioLaunch
Get an email before a deadline for this program, this school, or this state. The program never sees your address.
Student experiences · Read or add a note
Student notes
Buckeye BioLaunch
No posts yet.
Other programs at Ohio State University
Compare alternatives before you commit to one path.
News & articles
Ohio State establishes AI-enabled center for therapeutic discovery and development
Ohio State University
Ohio State University
Ohio State establishes AI-enabled center for therapeutic discovery and development
# Ohio State establishes AI-enabled center for therapeutic discovery and development News article June 30, 2026. New Buckeye BioLaunch initiative for AI-driven therapeutic discovery and commercialization. Partnership between Wexner Medical Center, OSUCCC-James, Colleges of Medicine and Pharmacy. 10-20 AI screening projects annually.
Read on Ohio State University
Compiled from public sources; not reviewed or endorsed by the school. Request a correction or removal.